Question Bank › Named catch-up gap

Named catch-up gap

Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos

Calls Tested
500
Answered YES
24
Hit Rate
4.8%
rare by design

Accuray Incorporated (ARAY) — this company's answers

NO on the Q4 2016 call 2016-08-17 B
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录，判断管理层是否明确指出公司当前在某个特定维度上表现不佳，并已着手缩小这一差距。 首先，寻找管理层承认的、具体的、可衡量的差距。在记录中，管理层提到了几个方面： 1. 服务毛利率：第四季度服务毛利率同比下降340个基点至32.9%，但管理层将其归因于一次性员工遣散费和其他一次性零件成本，以及500,000美元的过剩服务库存费用。他们表示，如果将这些一次性费用加回，服务毛利率将回到36%的运营率。这似乎不是持续性的差距，而是季度性的一次性影响。 2. 产品毛利率：第四季度产品毛利率同比上升360个基点至46.8%，这被归因于欧洲、中东和非洲地区的高利润率交易。管理层表示，产品毛利率的波动主要受产品组合和渠道影响。 3. 日本收入：管理层提到日本收入低于预期，原因是施工延误导致订单转化为收入的时间更长。这被归因于外部因素（施工延误），而非公司自身可控制的差距。 4. 定价压力：管理层提到，由于TomoTherapy在单双舱位点的成功，面临适度的定价压力，估计每年约500万美元。但他们认为，即使价格略低，由于增加了舱位和后续服务合同，净收益仍然为正。这似乎是一种权衡，而非未解决的差距。 5. 成本削减举措：管理层提到正在实施几项改进流程以降低销售成本，这些举措将在2017财年开始，但回报主要在2018财年。他们表示，2017财年的一次性投资是利润率扩张温和的原因之一。这似乎是一种计划中的改进，但尚未完全执行。 6. 库存管理：管理层提到库存同比增加约1000万美元，以支持更高的制造水平和服务库存，但目标是下财年结束时库存与现在相同或更低。这似乎是一种运营改进目标，但未明确说明当前库存水平是否是一个问题。 7. 区域表现：管理层提到亚太和日本地区在2016财年订单额和单位数均略有下降，但这是预期内的，因为2015年表现异常出色。他们预计2017财年将恢复温和增长。这似乎不是差距，而是周期性波动。 8. 产品组合：管理层提到，在美洲地区，单位数量增长约15%，但总金额持平，原因是产品组合和更多替换销售。这似乎是一种组合效应，而非差距。 现在，寻找管理层是否明确指出公司当前在某个特定维度上表现不佳，并已着手缩小差距。管理层没有明确说“我们在X方面落后于同行”或“我们的Y指标低于我们的潜力”。他们提到了一些改进举措，但大多是计划中的或归因于外部因素。 例如，关于成本削减举措，管理层说：“我们正在实施几项改进流程以降低销售成本。这些举措将在2017财年开始，回报从2018财年开始。”这听起来像是计划中的，而不是已经执行并产生效果的。他们还说：“我们将在2017财年看到这些成本削减举措开始影响损益表，但更大的贡献在2018财年。”这暗示着当前尚未实现。 关于服务毛利率，管理层将其归因于一次性费用，并说如果加回，将回到36%的运营率。这暗示着当前的低毛利率是暂时的，而非持续差距。 关于日本，管理层将其归因于施工延误，这是外部因素。 关于定价压力，管理层将其视为一种权衡，而非需要关闭的差距。 因此，管理层没有明确命名一个具体的、可衡量的差距，并描述已经进行中的工作来关闭它。他们提到了一些改进机会，但要么是计划中的，要么是归因于外部因素，要么是权衡而非差距。 因此，答案应为NO。

← Back to the full ARAY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management IDENTIFY A SPECIFIC, NAMED DIMENSION ON WHICH THE COMPANY CURRENTLY UNDERPERFORMS — relative to industry peers, industry norms, or the company's own demonstrated potential elsewhere in its business — AND describe work ALREADY UNDERWAY to close that specific gap, with management treating the closing of it as a meaningful source of improvement that does not depend on market conditions getting better? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent self-diagnosis with both halves present: (1) A NAMED GAP, OWNED BY MANAGEMENT: management itself states, concretely, where the company lags — for example margins, productivity, utilization, pricing, mix, service levels, penetration of its own customer base, or performance of one region, segment, or facility versus the company's own better ones or versus what peers demonstrably achieve — identified specifically enough that a reader knows exactly what is deficient and roughly how large the shortfall is; and (2) CLOSING WORK IN MOTION WITH THE MECHANISM EXPLAINED: management describes the concrete actions already executing to close it — not aspirations — and conveys why the gap is closable by the company's own effort (the better level is already achieved by peers or by the company's own best operations, so the target is demonstrated rather than theoretical), with early progress or a credible operational path visible in the current period. Answer NO if management only claims general improvement opportunity without naming a specific measurable gap. NO if the gap is blamed on external conditions that must improve. NO if the closing work is only planned, promised, or under study. NO if the gap-closing is ordinary cost-cutting rhetoric with no named benchmark. NO if the diagnosis appears only in an analyst's question that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
MEG Montrose Environmental Group, Inc. Q3 2023 2023-11-08 C+
RVLV Revolve Group, Inc. Q3 2023 2023-11-01 C
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
SWK Stanley Black & Decker, Inc. Q1 2023 2023-05-04 D
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
ADNT Adient plc Q1 2018 2018-01-29 D
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
STKL SunOpta Inc. Q2 2017 2017-08-09 C+
PTC PTC Inc. Q3 2017 2017-07-19 C+
ABM ABM Industries Incorporated Q2 2017 2017-06-08 B
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C
PDCO Patterson Companies, Inc. Q3 2017 2017-02-23 C
SXT Sensient Technologies Corporation Q4 2016 2017-02-10 A
BC Brunswick Corporation Q3 2016 2016-10-28 B+
SON Sonoco Products Company Q4 2015 2016-02-11 B

How the model reasoned

HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.

More from the question bank

Paid to expand: the company's growth spendinThe product is disappearing into reorder rhyRecently unlocked doorWorking for customers it could not have servVolume records through a still-fixed gateTwo-sided intensityAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.